Aibo Medical: Net profit in the first half of 2025 was 213 million yuan, a year-on-year increase of 2.53%.

Aibo Medical announced that its operating income in the first half of 2025 was 787 million yuan, an increase of 14.72% compared to the same period last year. Net profit was 213 million yuan, an increase of 2.53% compared to the same period last year. The company issued stocks to specific entities and accumulated profits during the reporting period, leading to total assets of 3.933 billion yuan, an increase of 12.47% compared to the same period last year. The total R&D investment of the company was 83.3819 million yuan, an increase of 21.55% compared to the same period last year, accounting for 10.60% of the operating income.